Mounjaros active ingredient is tirzepatide while Ozempics is semaglutide
Already, KDIGO (kidney guidelines) in 2020 recommended GLP-1 RA as part of glycemic management in diabetics with CKD who need additional therapy after metformin, especially if at CV risk
Reduce Appetite Helps you feel fuller, fasterso you naturally eat less without feeling deprived
This sensation of early satiety occurs because GLP-1 slows gastric emptying, meaning food remains in your stomach longer, triggering fullness signals more readily
Studies have also demonstrated that it can influence over 4,000 genes, turning off processes that damage tissue while activating those critical for healing (3)
chemically bond into an entirely new molecule that isnt found in any FDA-approved product and hasnt been tested for safety or effectiveness